1. Home
  2. TAYD vs CRDL Comparison

TAYD vs CRDL Comparison

Compare TAYD & CRDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TAYD
  • CRDL
  • Stock Information
  • Founded
  • TAYD 1955
  • CRDL 2017
  • Country
  • TAYD United States
  • CRDL Canada
  • Employees
  • TAYD N/A
  • CRDL N/A
  • Industry
  • TAYD Industrial Machinery/Components
  • CRDL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • TAYD Industrials
  • CRDL Health Care
  • Exchange
  • TAYD Nasdaq
  • CRDL Nasdaq
  • Market Cap
  • TAYD 114.6M
  • CRDL 80.1M
  • IPO Year
  • TAYD N/A
  • CRDL N/A
  • Fundamental
  • Price
  • TAYD $35.47
  • CRDL $1.46
  • Analyst Decision
  • TAYD
  • CRDL Strong Buy
  • Analyst Count
  • TAYD 0
  • CRDL 3
  • Target Price
  • TAYD N/A
  • CRDL $9.33
  • AVG Volume (30 Days)
  • TAYD 12.2K
  • CRDL 232.2K
  • Earning Date
  • TAYD 08-14-2025
  • CRDL 05-14-2025
  • Dividend Yield
  • TAYD N/A
  • CRDL N/A
  • EPS Growth
  • TAYD 1.48
  • CRDL N/A
  • EPS
  • TAYD 2.50
  • CRDL N/A
  • Revenue
  • TAYD $42,796,782.00
  • CRDL N/A
  • Revenue This Year
  • TAYD $15.06
  • CRDL N/A
  • Revenue Next Year
  • TAYD $8.37
  • CRDL N/A
  • P/E Ratio
  • TAYD $14.17
  • CRDL N/A
  • Revenue Growth
  • TAYD N/A
  • CRDL N/A
  • 52 Week Low
  • TAYD $29.50
  • CRDL $0.77
  • 52 Week High
  • TAYD $64.50
  • CRDL $3.00
  • Technical
  • Relative Strength Index (RSI)
  • TAYD 47.30
  • CRDL 67.58
  • Support Level
  • TAYD $33.67
  • CRDL $1.35
  • Resistance Level
  • TAYD $36.71
  • CRDL $1.49
  • Average True Range (ATR)
  • TAYD 1.47
  • CRDL 0.10
  • MACD
  • TAYD -0.34
  • CRDL 0.01
  • Stochastic Oscillator
  • TAYD 41.57
  • CRDL 89.53

About TAYD Taylor Devices Inc.

Taylor Devices Inc is involved in the design, development, manufacture, and marketing of shock absorption, rate control, and energy storage devices for use in various types of machinery, equipment, and structures. The company's product line includes Seismic dampers, Fluidicshoks, Crane and industrial buffers, Self-adjusting shock absorbers, Liquid die springs, and Vibration Dampers. Its products are generally used to absorb, control, or mitigate the motion of masses caused by earthquakes or explosions. The company markets its products to various industries such as industrial, steel mills, buildings, bridges, aerospace, defense, and automotive industries.

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.

Share on Social Networks: